Setting the Global Standards for Medical Affairs, Together!

The mission of Elevate is to educate, empower and inspire, leading the transition to a future-ready, value-driven Medical community.

Healthcare has the potential to be radically transformed by digital technology and we believe that the most competitive pharmaceutical companies in the coming decade will leverage data and digital technologies to drive differentiating services and will be in the forefront of pushing the boundaries of digital innovation. These leaders will generate and analyze vast volumes of research and real-world data to discover transformational medicines and will excel at communicating scientific evidence to stakeholders. They will help physicians navigate in a far more sophisticated and complex healthcare ecosystem and help them make difficult decisions that are the right decisions for patients. Medical Affairs teams can become a strategic force for pharmaceutical companies in this journey with their deep scientific knowledge and disease understanding.

Mary Alice Dwyer, MAPS Executive Leadership Committee member and Lead of the Digital Focus Area Working Group, Principal Consultant, Medical Innovation and Insights and former Vice President, Global Medical Excellence and Patient Centricity, Global Medical Affairs, AstraZeneca and Shaji Kalathil, Executive Director, Global Head of IT for Medical Affairs, Bristol-Myers Squibb discuss how advancements in transformative technologies are driving a new wave of digital innovation opportunities for Medical Affairs

Mary Alice Dwyer

There is a tremendous opportunity for Medical Affairs to be leaders in advancing digital innovation and truly change how they engage Health Care Providers and patients. Through the strategic implementation of digital innovation, Medical Affairs can embrace technology that will transform not only what we deliver, but how we engage with HCPs and patients. Exploring technologies like AI and ML and other innovative tools will further define the impact Medical Affairs can have.

Shaji Kalathil

These are exciting times in the pharmaceutical industry with fast- paced digital innovation and the potential to transform the Medical Affairs customer engagement model and data generation capabilities with disruptive technologies, artificial intelligence and advanced analytics. I also envision significant advancements in “beyond the product” digital solutions and services for complex therapies in the future that will improve patient outcomes and Medical Affairs becoming the custodian of these services.

January 22, 2020

What are the most important things leaders like you should take into consideration for success in driving digital innovation for Medical affairs?

To ensure success in driving digital innovation many factors need to be in place. Leaders need to be ready to build the right capabilities and this […]

January 22, 2020

We are seeing an increasing number of technology innovators focusing on healthcare. How do you foresee this external innovation fueling Medical Affairs in driving transformative digital capabilities?

There are considerable opportunities to build more effective partnerships with pure play technology companies that will address complex problems in healthcare. We need to think in […]

January 22, 2020

There is a lot of buzz about the possibilities with artificial intelligence in pharma. How do you envision digital innovation impacting Medical Affairs with advancements in artificial intelligence?

Medical Affairs is consistently being expected to work with growing amounts of data, whether this data comes from insights, Real World Data, or working with the […]

January 22, 2020

What are the most promising things you are seeing in the technology landscape that can transform Medical Affairs?

There is no better time than now to embrace disruptive digital technologies in the pharma industry. I am most excited about three technology trends with the […]

January 22, 2020

If you look towards the future (5-10 years) what areas of Medical Affairs would you see as completely transformed by digital innovation and how will you describe the business impact of this transformation?

I believe all parts of Medical Affairs have the opportunity to transform, both by improving operational efficiency and through delivering a more tailored “customer-focused” engagement. I […]

January 22, 2020

How do you think digital innovation can advance the medical insights capabilities?

Digital innovation can play an impactful role in transforming the medical insights capability in two areas – the way our customer facing teams in Medical Affairs […]

January 22, 2020

There seems to be great interest on the topic of customer insights generation by Medical Affairs to shape strategy and impactful customer engagement. Can you share your perspectives?

Medical Affairs has a tremendous opportunity to impact how our organizations understand the healthcare landscape as well as the HCP and the patient’s perspective. We are […]

January 22, 2020

How do you foresee the evolution of the Medical Affairs customer engagement model in the future and the impact of digital innovation?

Medical Affairs leaders continue to expand their role in “customer” engagement, whether the customer is the health care provider (HCP) or the patient. While Medical Affairs […]